GLP-1 medications may cause gastrointestinal symptoms, such as: Nausea Vomiting Diarrhea Constipation These tend to happen most often when increasing doses, but usually improve over time
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimers disease
Protein synthesis acts like a construction crew that builds new tissue from amino acid building blocks
It is known as a triple-agonist , meaning it targets GLP-1, GIP, and glucagon receptors simultaneously
Es decir, resulta muy interesante en el ejercicio ya que existe una mayor quema de grasa con un mantenimiento del glucgeno muscular y esto favorece al rendimiento ya que este se incrementa, y disminuye la fatiga de forma considerable